Drug Detail:Brimonidine (eent) (monograph) (Alphagan p)
Drug Class:
Usual Adult Dose for Intraocular Hypertension
1 drop in the affected eye(s) 3 times per day, approximately 8 hours apart
Comments:
- This drug may be used concomitantly with other topical ophthalmic drugs.
- If more than one topical ophthalmic drug is being used, the products should be administered at least 5 minutes apart.
Use: To lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Usual Adult Dose for Glaucoma (Open Angle)
1 drop in the affected eye(s) 3 times per day, approximately 8 hours apart
Comments:
- This drug may be used concomitantly with other topical ophthalmic drugs.
- If more than one topical ophthalmic drug is being used, the products should be administered at least 5 minutes apart.
Use: To lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Usual Pediatric Dose for Intraocular Hypertension
2 years or older:
1 drop in the affected eye(s) 3 times per day, approximately 8 hours apart
Comments:
- This drug may be used concomitantly with other topical ophthalmic drugs.
- If more than one topical ophthalmic drug is being used, the products should be administered at least 5 minutes apart.
Use: To lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Usual Pediatric Dose for Glaucoma (Open Angle)
2 years or older:
1 drop in the affected eye(s) 3 times per day, approximately 8 hours apart
Comments:
- This drug may be used concomitantly with other topical ophthalmic drugs.
- If more than one topical ophthalmic drug is being used, the products should be administered at least 5 minutes apart.
Use: To lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Renal Dose Adjustments
Renal impairment: Use with caution
Liver Dose Adjustments
Liver impairment: Use with caution
Precautions
Safety and efficacy have not been established in patients younger than 2 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Patient advice:
- Pressure should be applied to the tear duct immediately following administration of the drug.
- This drug may cause blurred and/or abnormal vision, fatigue and/or drowsiness, which may impair the ability to drive or operate machinery.
- To avoid contamination of the solution, the container should be kept tightly closed.